Utilizing the contractors technology, human induced pluripotent stem cells will undergo differentiation to pre-megakaryocytes (premk+), which are stockpiled through cryopreservation. Frozen premk+ are…
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50119C00039
- Awardee
-
Platelet Biogenesis, Inc. UEI Z2JQDS7NE471
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $4,998,785
Award facts
- Opportunity
-
- JAVASCRIPTSELECTERRORITE Solicitation number
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Award Notice · Posted Sep 27, 2019
- Contract value 100% obligated
- $4,998,785.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $4,998,785 |
About this award
This is a cost-plus-fixed-fee definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Platelet Biogenesis, Inc. The contract, valued at $4,998,785.00, requires the contractor to utilize its technology to differentiate human induced pluripotent stem cells into pre-megakaryocytes, which are then cryopreserved. The frozen pre-megakaryocytes will be thawed and further differentiated into mature megakaryocytes. This contract does not have a set-aside designation and is scheduled for completion on August 31, 2024.
Description
Utilizing the contractors technology, human induced pluripotent stem cells will undergo differentiation to pre-megakaryocytes (premk+), which are stockpiled through cryopreservation. Frozen premk+ are thawed and further differentiated to mature megak
Quick answers
Who was awarded contract 75A50119C00039?
75A50119C00039 was awarded to Platelet Biogenesis, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 20, 2019.
How much is contract 75A50119C00039 worth?
The government has obligated $4,998,785 on 75A50119C00039.
Was contract 75A50119C00039 competed?
The extent of competition for 75A50119C00039 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award